Results 201 to 210 of about 76,033 (333)

Are the cardiovascular outcomes of participants with white-coat hypertension poor compared to those of participants with normotension? A systemic review and meta-analysis

Hypertension Research, 2019
T. Fujiwara, C. Matsumoto, K. Asayama, T. Ohkubo, S. Hoshide   +4 more
semanticscholar   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

HADS-A in White Coat Hypertension: Limitations and Future Directions. [PDF]

Anatol J Cardiol
Li Y, Sun P, Xu Z, Zhao X.
europepmc   +1 more source

American Versus European Hypertension Guidelines: The Case of White Coat Hypertension. [PDF]

Am J Hypertens, 2020
Cuspidi C, Paoletti F, Tadic M, Sala C, Dell'Oro R, Grassi G, Mancia G.   +6 more
europepmc   +1 more source

White coat hypertension in early pregnancy in women with pre-existing diabetes: prevalence and pregnancy outcomes

Diabetologia, 2019
M. Vestgaard, B. Ásbjörnsdóttir, L. Ringholm, L. Andersen, D. M. Jensen, P. Damm, E. Mathiesen   +6 more
semanticscholar   +1 more source

Bioavailability of Magnesium and Potassium Salts Used as Potential Substitutes for Sodium Chloride in Human Nutrition — A Review

Molecular Nutrition &Food Research, EarlyView.
A high intake of sodium chloride contributes to hypertension. This review evaluates the bioavailability of potassium and magnesium salts as sodium chloride alternatives. Potassium chloride and citrate, as well as magnesium citrate and chloride, show good absorption.
Ronja Merschmann, Carlotta Burgmer, Gunter P. Eckert, Anika E. Wagner   +3 more
wiley   +1 more source

Reply to Letter to the Editor: "HADS-A in White Coat Hypertension: Limitations and Future Directions". [PDF]

Anatol J Cardiol
Güler Y, Genç Ö, Yıldırım A, Halil US, Çapar G, Özdoğan CG, Erdoğan A, Güler A, Kırma C.   +8 more
europepmc   +1 more source

White coat hypertension: European versus American guidelines-A new dilemma. [PDF]

J Clin Hypertens (Greenwich), 2020
Cuspidi C, Paoletti F, Tadic M.
europepmc   +1 more source

L22 Target organ damage in subjects with white-coat and sustained hypertension: An insight from the harvest study [PDF]

, 1997
Paolo Palatini
openalex   +1 more source

Characteristics, properties and limitations of per‐ or polyfluoroalkyl substances (PFASs) and fluoropolymers

Polymer International, EarlyView.
An overview and categorization of man‐made per‐ or polyfluoroalkyl substances (PFASs) including low‐molar‐mass and high‐molar‐mass fluorochemicals, and their international regulations is presented. Though certain PFASs are toxic, bioaccumulative and cross the human cellular membranes, others, such as fluoropolymers, are safe, reliable and involved in ...
Bruno Améduri
wiley   +1 more source